Status | Study |
Completed |
Study Name: Clinical Trial in 22q13 Deletion Syndrome(Phelan-McDermid Syndrome) Condition: 22q13 Deletion Syndrome Phelan-McDermid Syndrome Date: 2012-02-01 Interventions: Drug: Insulin-Like Growth Factor-1 (IGF-1) |
Completed |
Study Name: Study of the Pathophysiological Mechanisms Involved in Bleeding Events Condition: Oculocerebrorenal Syndrome Date: 2011-03-11 Interventions: Other: Blood sample Blood sample |
Terminated |
Study Name: A Dose Range Finding Study of Lenalidomide in Non-5q Chromosome Deletion in Low and Intermediate Risk Myelodysplastic Syndrome (MDS) Patients Condition: Myelodysplastic Syndrome MDS Low to Intermediate-1 MDS Date: 2008-06-13 Interventions: Drug: Lenalidomide Dose Level Lenalidomide Schedule |
Recruiting |
Study Name: Treatment Strategies for Children With Smith-Magenis Syndrome Condition: Developmental Delay Disorders Chromosome Deletion Date: 2007-07-21 Interventions: Drug: dTR Melatonin (NIH CC PDS) Device: P |
Completed |
Study Name: Celiprolol in Patients With Ehlers-Danlos Syndrome, Vascular Type Condition: EHLERS-DANLOS SYNDROME, TYPE IV, AUTOSOMAL DOMINANT CHROMOSOME 2q31.2 DELETION SYNDROME Date: 2005-09-13 Interventions: Drug: celiprolol celiprolol |
Completed |
Study Name: Positional Cloning of the Gene(s) Responsible for Alagille Syndrome Condition: Alagille Syndrome Date: 2000-04-06 |